- Report
- November 2023
- 175 Pages
Global
From €4710EUR$5,000USD£4,027GBP
- Report
- January 2024
- 113 Pages
United States
€3297EUR$3,500USD£2,819GBP
- Report
- March 2023
- 30 Pages
Global
€11539EUR$12,250USD£9,867GBP
- Report
- April 2025
- 50 Pages
Global
From €2496EUR$2,650USD£2,135GBP
Acitretin is a systemic retinoid drug used to treat psoriasis, a chronic skin condition. It is a synthetic form of vitamin A and works by reducing the production of skin cells and suppressing inflammation. Acitretin is usually prescribed for moderate to severe psoriasis that has not responded to other treatments. It is taken orally and is available in capsule form. Common side effects include dry skin, itching, and hair loss.
The acitretin market is a subset of the psoriasis drugs market. It is a growing market, driven by the increasing prevalence of psoriasis and the need for effective treatments. Acitretin is a popular choice for treating psoriasis due to its efficacy and relatively low risk of side effects.
Some companies in the acitretin market include Stiefel Laboratories, Inc., Mylan N.V., and Sun Pharmaceutical Industries Ltd. Show Less Read more